Jun 16, 2025 8:00am EDT Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule
May 29, 2025 8:00am EDT Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital